Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study

Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study

Indeterminate thyroid nodules (ITN) represent 20–30% of biopsied nodules, with a 10–60% risk of malignancy. Molecular testing can stratify the risk of malignancy among ITNs, and subsequently reduce the need for unnecessary diagnostic surgery. We aimed to assess the performance of these molecular tes...

Full description

Bibliographic Details
Main Authors: Emad Kandil, Tyler A. Metz, Peter P. Issa, Mohamed Aboueisha, Mahmoud Omar, Abdallah S. Attia, Bert Chabot, Mohammad Hussein, Krzysztof Moroz, Mohamed Shama, Eman Toraih
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
indeterminate thyroid nodules
Afirma
Interpace Diagnostic
statistical measures
genetic testing
Online Access:https://www.mdpi.com/2072-6694/15/7/2098

Internet

https://www.mdpi.com/2072-6694/15/7/2098

Similar Items